Navigation Links
Small Army Takes on Cure for Diabetes and New Approach to Ending World Poverty with Addition of Non-Profit Accounts
Date:9/24/2007

Boston-based Agency Signs The Iacocca Foundation and S.E.VEN

BOSTON, Sept. 24 /PRNewswire/ -- Small Army, the Boston-based marketing and creative services agency, has added finding a cure for diabetes and alleviating world poverty to their scope of work with the addition of The Iacocca Foundation and S.E.VEN.

"As communicators, we welcome the challenge to partner with organizations whose mission is not driven by dollars, but by a commitment to truly make the world a better place", said Jeff Freedman, Small Army co-founder and marketing principal. "The Iacocca Foundation and S.E.VEN are both propelled by unique and intelligent models which will make these relationships even more fruitful."

Small Army will work with the Iacocca Foundation on strategic planning and creative development, culminating with new collateral and marketing materials. Additionally, the agency is launching a separate website where Mr. Iacocca will share his thoughts on leadership and discuss the fight against diabetes, among other topics.

"We're excited at the potential of more quickly reaching our goal through a partnership with Small Army," said Dana Ball, Executive Director of The Iacocca Foundation "Their sincere belief in our mission enhances their impact in helping us more effectively tell our story."

For S.E.VEN - a nonprofit organization committed to using entrepreneurial means to bring an end to global poverty - the agency will undertake a positioning launch including development of a logo and identity.

"The team at Small Army clearly demonstrated an ability to think both strategically and creatively about our mission - that's exactly the support we will need in our work to alter entrenched thinking about global poverty," said Andreas Wilmer, co-director of the S.E.VEN Fund.

The Iacocca Foundation, founded by former Chrysler CEO, Lee Iacocca, is committed to finding a cure for diabetes. Unique in the field of diabetes investigation, The Iacocca Foundation actively seeks and supports research initiatives which are at the early stages of development, but demonstrate potential for industry-changing breakthroughs to accelerate a cure. Recently, the Foundation raised more than $11 million to support a research project at Mass General Hospital, which has since demonstrated that, for the first time, end-stage diabetes can be reversed through cell regeneration.

S.E.VEN, the Social Equity Venture Fund, aims to challenge current assumptions and generate new ways of thinking about solving world poverty. As an independent nonprofit organization, supported by a grant from the John Templeton Foundation, S.E.VEN provides monetary, organizational and intellectual support for the research of enterprise based solutions to poverty-exploring how entrepreneurship can lead to wealth generation in poverty-stricken nations.

About Small Army

Small Army (http://www.smallarmy.net) is a Boston-based, full-service marketing and creative services agency, founded in 2002 by Marketing Principal Jeff Freedman and Creative Principal Mike Connell. The agency provides a unique blend of strategic insight, creative acumen and technology expertise to create, measure and continually enhance effective marketing campaigns for clients across a range of industries. Small Army has built a roster of clients including: Bugaboo Creek Steak House, Cynosure, Beth Israel Deaconess Medical Center, Boston Magazine, Dunham, the Massachusetts Office of Travel and Tourism and One Beacon.

Contact: Jane Kuby, 617/512-0648, msjkuby@hotmail.com


'/>"/>
SOURCE Small Army
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Small lumps in breast if not treated may cause long-term harm
2. Smallpox as Biological Weapons?
3. Is Smallpox Threat Real ?
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Smallpox Would Spread Rapidly
6. Problematic Use of smallpox vaccine
7. Drug Firm Offers to Donate Smallpox Vaccine
8. Small aneurysms best left untouched
9. Researchers developed world’s smallest toothbrus
10. Third generation Small pox vaccine from Cell-culture
11. Discovery of World’s smallest laser
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... Valentine’s Day is nearly upon us, and most singles ... great outfit, flawless hair, and a sparkling personality are all well and good, but ... night at home with Rover. (Actually, man’s best friend might not even want to ...
(Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy lifestyle ... reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those giving ... high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV are ... The increasingly modern world of instantaneous consumption proves very convenient for businesses. With new ... oil and coal, which pollutes our air, water, and soil. It can also threaten ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, Inc. presented ... a VeinViewer® Vision vein finder for the nursing school simulation lab. ... and draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
Breaking Medicine Technology: